Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Progress in Hepatitis C researchBaltimore SunBy Meredith Cohn, The Baltimore Sun Hepatitis C has long been a problem with a low rate of cure. But new drug therapies are in use and others are on the horizon, according to Dr. J. Thuluvath, chief of gastroenterology at Mercy Medical Center and ...See all stories on this topic »

Anadys' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious ...MarketWatch (press release)"This recognition reflects the scarcity of later-stage development assets in hepatitis C and the strong desire on the part of companies to assemble combination regimens to treat this disease. With a readout next month of the 12-week data from an ...See all stories on this topic »

Pharmasset climbs after study result releasedBusinessWeekBy AP Drug developer Pharmasset Inc. hit a "home run" with results from a mid-stage study of a potential hepatitis C virus treatment, according to a Citi analyst. THE SPARK: Pharmasset, based in Princeton, NJ, said Tuesday results from a study of the ...See all stories on this topic »

New Treatment Options Are On The Horizon For People Co-Infected With HIV And ...The AIDS BeaconAccording to a recent review, the new hepatitis C treatment options Victrelis and Incivek may soon be available for people with HIV and hepatitis C. In the meantime, the authors suggested that strategies be developed to optimize management of hepatitis ...See all stories on this topic »

Gilead Amends HCV Combo StudyInvestorIdeas.com (press release)Gilead is hoping to build one of the largest hepatitis C pipelines with six compounds in clinical development. Moreover Gilead is also developing proprietary drug combinations which aim to reduce treatment duration to 12-16 weeks and spare the use of ...See all stories on this topic »

Santaris Pharma A/S Showcases microRNA and mRNA Research Advancements ...MarketWatch (press release)"The Company is providing an update on the progress of its lead microRNA-targeted drug candidate, miravirsen, for the treatment of Hepatitis C; presenting data on the use of Santaris Pharma A/S proprietary

'tiny' LNA-based drugs to inhibit entire ...See all stories on this topic »

Achillion CEO Needs to Deliver on Deal TalkTheStreet.comAchillion expects to release proof-of-concept data from studies of three different experimental hepatitis C drugs before the end of the year, said Kishbauch. Among the expected results are 12-week, early virologic response data from a mid-stage study ...See all stories on this topic »

Fresno Needle Exchange Program Presses OnKSEEThe goal is to prevent the spread of diseases like HIV and hepatitis C. Director Dallas Blanchard says it also protects the community. "When a law enforcement officer comes in contact with someone who has needles, they're properly containerized and ...See all stories on this topic »

CORRECTED - UPDATE 3-Vertex rheumatoid arthritis drug meets study goalsReutersThe company, which in May launched its first commercial product -- the hepatitis C treatment Incivek -- plans to evaluate VX-509 in a six,-month mid-stage study based on results of the 12-week trial. VX-509 targets a protein known as JAK3, ...See all stories on this topic »

Accused killer testifies in his own defenseSalt Lake TribuneWhen Strate saw Sidwell bleeding above his eye, Strate said he jumped up immediately because he knew his brother-in-law had Hepatitis C. That's when Sidwell went toward the closet and picked up a drummer's stool. "I pulled my gun out. ...See all stories on this topic »